Haemonetics (HAE) Free Cash Flow Growth (3y) (2012 - 2026)
Haemonetics (HAE) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 9.23% |
| 10 | Haemonetics | 4.93 Bn | 4.70 Bn | 202.80 Mn | 57.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 57.33% |
| Mar 28, 2026 | 81.34% |
| Dec 27, 2025 | 22.39% |
| Sep 27, 2025 | 27.67% |
| Jun 28, 2025 | 80.97% |
| Mar 29, 2025 | 45.24% |
| Dec 28, 2024 | -0.52% |
| Sep 28, 2024 | 20.26% |
| Jun 29, 2024 | -28.47% |
| Mar 30, 2024 | 97.39% |
| Dec 30, 2023 | -31.36% |
| Sep 30, 2023 | 62.92% |
| Jul 1, 2023 | 40.46% |
| Apr 1, 2023 | -33.44% |
| Dec 31, 2022 | -6.87% |
| Oct 1, 2022 | 35.73% |
| Jul 2, 2022 | 14.82% |
| Apr 2, 2022 | 68.19% |
| Jan 1, 2022 | 7.34% |
| Oct 2, 2021 | 36.68% |